Government
Medicare pays more for drugs than Medicaid
NEWS IN BRIEF — Posted Aug. 11, 2008
Medicare Part D pays on average 30% more for drugs than Medicaid, which resulted in a "windfall" worth billions for drugmakers in the first two years of the benefit alone, according to a new report from House Democratic lawmakers.
In July, majority staff members from the House Committee on Oversight and Government Reform released the study, which compared medication prices negotiated by Medicare drug plans with the prices paid by Medicaid. Because about 6 million Medicare-Medicaid "dual eligibles" transferred to Part D after its launch in 2006, the report estimates that the government spent roughly $3.7 billion more over the two years than it would have if the beneficiaries had continued to receive their drugs through Medicaid.
Henry Waxman (D, Calif.), the committee's chair, is drafting legislation that would prohibit the Medicare drug benefit from paying more for dual eligible coverage than Medicaid pays for its drugs. The Bush administration and drug manufacturers oppose the move, calling it an example of harmful price controls.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2008/08/11/gvbf0811.htm.












